Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
18.5 EUR | -1.07% | +17.98% | -30.97% |
Apr. 09 | BASTIDE LE CONFORT MEDICAL : EPS upgrade (2023: 0.0%, 2024: +1.6%) | |
Apr. 09 | Bastide: new contract with the British NHS | CF |
Sales 2024 * | 530M 570M | Sales 2025 * | 564M 607M | Capitalization | 139M 149M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.2M | Net income 2025 * | 22M 23.65M | EV / Sales 2024 * | 0.9 x |
Net Debt 2024 * | 337M 362M | Net Debt 2025 * | 331M 356M | EV / Sales 2025 * | 0.83 x |
P/E ratio 2024 * |
8.19
x | P/E ratio 2025 * |
5.99
x | Employees | 3,635 |
Yield 2024 * |
2.51% | Yield 2025 * |
2.58% | Free-Float | 44.92% |
1 day | -1.07% | ||
1 week | +17.98% | ||
Current month | +31.21% | ||
1 month | +23.33% | ||
3 months | -11.90% | ||
6 months | -12.32% | ||
Current year | -30.97% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 18.5 | -1.07% | 7 788 |
24-05-02 | 18.7 | +3.89% | 14,501 |
24-04-30 | 18 | -1.10% | 21,889 |
24-04-29 | 18.2 | +3.29% | 19,573 |
24-04-26 | 17.62 | +5.13% | 30,215 |
Real-time Euronext Paris, May 03, 2024 at 08:32 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.97% | 148M | |
-2.77% | 3.02B | |
0.00% | 1.89B | |
+5.97% | 1.59B | |
+52.30% | 637M | |
-3.48% | 501M | |
-37.21% | 358M | |
-11.94% | 141M | |
+1.92% | 70.36M |
- Stock Market
- Equities
- BLC Stock